efatutazone

DRUG2 trials

Sponsors

Alliance for Clinical Trials in Oncology

Conditions

Anaplastic Thyroid CancerLiposarcomaRecurrent Thyroid Cancer

Phase 2

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

CompletedNCT02152137

Alliance for Clinical Trials in OncologyAnaplastic Thyroid Cancer, Recurrent Thyroid Cancer

Start: 2014-12-30End: 2023-04-15Updated: 2025-01-27

Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

CompletedNCT02249949

Alliance for Clinical Trials in OncologyLiposarcoma

Start: 2015-02-11End: 2023-05-01Updated: 2025-01-27